脑血疏口服液治疗中风临床应用专家共识

Expert consensus on the clinical application of Naoxueshu oral liquid(脑血疏口服液)in the treatment of stroke

脑血疏口服液具有益气、活血、化瘀的功效,临床上广泛用于气虚血瘀所致中风的治疗。经多年临床观察,其对出血性中风、缺血性中风等有明显疗效,受到多个指南、共识及丛书的推荐。在总结临床医生应用经验的基础上,结合现有循证证据,遵照《中华中医药学会中成药临床应用专家共识报告规范》等,在问卷调查和文献系统回顾的基础上,基于现有最佳证据,充分结合专家经验,遵循“循证为主,共识为辅,经验为鉴”的原则,通过名义组法共达成16条推荐意见/共识建议,提出了脑血疏口服液治疗中风的用药时机、临床疗效、用法用量、疗程等,并说明了临床应用的安全性。该共识适用于各级医疗机构的医师在使用脑血疏口服液时作为用药参考。旨在提高脑血疏口服液治疗中风的临床疗效,促进合理用药,减少用药风险。共识已通过中华中医药学会的审核,并进行了发布,编号GS/CACM 331-2023。

Naoxueshu Oral Liquid(脑血疏口服液)has the effects of nourishing Qi,promoting blood circulation and resolving blood stasis.It is widely used in clinical practice for the treatment of stroke caused by Qi deficiency and blood stasis.After years of clinical observation,it has shown significant therapeutic effects on hemorrhagic stroke,ischemic stroke,etc.,and has been recommended by multiple guidelines,consensus and series of books.On the basis of summarizing clinical doctors'application experience,combined with the existing evidence-based evidence,in accordance with Reporting Standards for Expert Consensus on Clinical Practice of Chinese Patent Medicines of China Association of Chinese Medicine,on the basis of questionnaire survey and literature system review,based on the best available evidence,fully combined with expert experience,and following the principle of“evidence-based,consensus supplemented,experience as a mirror”,this paper reached 16 recommendations/consensus recommendations through the nominal method of grouping,proposed the timing,clinical efficacy,dosage and course of treatment of Naoxueshu Oral Liquid in the treatment of stroke,and explained the safety of clinical application.This consensus applies to physicians at all levels of medical institutions as a reference for medication when using Naoxueshu Oral Liquid.It is intended to improve the clinical efficacy of Naoxueshu Oral Liquid in the treatment of stroke,promote rational medication and reduce medication risks.This consensus has been reviewed and published by the China Association of Traditional Chinese Medicine,with the number GS/CACM 331-2023.